98%
921
2 minutes
20
Purpose: Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with adverse reproductive and obstetric outcomes, particularly in pregnancies achieved through assisted reproductive technologies. This study aimed to compare obstetric outcomes among programmed cycle-frozen embryo transfer (PC-FET), modified natural cycle-frozen embryo transfer (mNC-FET), and natural cycle-frozen embryo transfer (NC-FET) in women with PCOS using a nationwide Korean health claims database.
Methods: This population-based cohort study utilized data from the National Health Insurance Service-National Health Information Database of South Korea. A retrospective analysis was conducted on 3,873 PCOS patients with singleton pregnancies following FET between October 2017 and December 2021. Patients were categorized into PC-FET, mNC-FET, and NC-FET groups based on prescription records. Obstetric outcomes were analyzed using logistic regression models adjusted for age and medical comorbidities.
Results: mN-FET was associated with significantly lower rates of miscarriage (23.9%) compared to PC-FET (31.3%) and NC-FET (32.0%), as well as a higher term birth rate (69.6% vs. 61.7% and 60.2%, respectively). mNC-FET also showed significantly lower rates of hypertensive disorders of pregnancy, gestational hypertension, cesarean section, and emergency cesarean section compared to PC-FET. No significant differences were observed between mNC-FET and NC-FET in most obstetric complications.
Conclusion: mNC-FET was associated with favorable obstetric outcomes compared to PC-FET and NC-FET in women with PCOS. These findings suggest that mNC-FET may be an effective and safer endometrial preparation strategy in this population. Further prospective studies are needed to validate these results and optimize FET protocols based on individual patient characteristics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10815-025-03523-4 | DOI Listing |
JAMA Pediatr
September 2025
Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Importance: Neonatal intensive care has advanced over recent decades, yet premature birth remains associated with increased neonatal mortality and morbidity.
Objective: To describe health service use, morbidity, and medication needs up to age 5 years in a contemporary cohort of children born preterm.
Design, Setting, And Participants: This population-based cohort study was conducted in British Columbia (BC), Canada, using health service and pharmacy data linked using provincial administrative databases.
JAMA Intern Med
September 2025
Bayer CC AG, Basel, Switzerland.
Importance: There is an unmet need for long-term, safe, effective, and hormone-free treatments for menopausal symptoms, including vasomotor symptoms (VMS) and sleep disturbances.
Objective: To evaluate the 52-week efficacy and safety of elinzanetant, a dual neurokinin-targeted therapy, for treating moderate to severe VMS associated with menopause.
Design, Setting, And Participants: OASIS-3 was a double-blind, placebo-controlled, randomized phase 3 clinical trial that was conducted at 83 sites in North America and Europe from August 27, 2021, to February 12, 2024, and included postmenopausal women aged 40 to 65 years who were seeking treatment for moderate to severe VMS (no requirement for a minimum number of VMS events per week).
JAMA
September 2025
Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, the Netherlands.
Importance: Pregnant individuals with polycystic ovary syndrome (PCOS) present with a higher risk of pregnancy complications, including gestational diabetes, preeclampsia, and preterm birth. Myo-inositol supplementation may reduce these risks.
Objective: To determine whether daily supplementation with myo-inositol during pregnancy among individuals with PCOS reduces the risk of a composite outcome of gestational diabetes, preeclampsia, and preterm birth.
JAMA Pediatr
September 2025
Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Importance: For the first time in nearly 2 decades, the US infant mortality rate has increased, coinciding with a rise in overdose-related deaths as a leading cause of pregnancy-associated mortality in some states. Prematurity and low birth weight-often linked to opioid use in pregnancy-are major contributors.
Objective: To assess the health and economic impact of perinatal opioid use disorder (OUD) treatment on maternal and postpartum health, infant health in the first year of life, and infant long-term health.
JAMA Netw Open
September 2025
Yale School of Medicine, New Haven, Connecticut.
Importance: Approximately 35% of individuals seeking abortion care use Medicaid for health insurance. Although the Hyde Amendment restricts use of federal funds for most abortions, states can supplement coverage using state funds. Understanding the scope of abortion coverage across states and potential barriers to access may help address health care inequities and inform interventions.
View Article and Find Full Text PDF